When the body does not collaborate: pharmacological treatment of obesity
The paper presents the modern evidence on pharmacological treatment of patients with obesity and comorbidities, who try to modify their lifestyle, but are unsuccessful due to metabolic disturbances. The main and recently discovered additional effects of orlistat are discussed.
Main Author: | E. O. Taratukhin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2013-08-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/406 |
Similar Items
-
Cardiovascular risk in type 2 diabetes patients
by: O. D. Ostroumova, et al.
Published: (2018-08-01) -
Dislipidemia and Serum Level of Interleukin-22 in Hyptrtensive Patients with Concomitant Excessive Body Weight or Obesity
by: Kovalyova O., et al.
Published: (2017-12-01) -
EFFICACY AND SAFETY OF BISOPROLOL IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND OBESITY
by: A. G. Avtandilov, et al.
Published: (2016-01-01) -
Vitamin D Status and Cardio-Metabolic Risk in Indian Postmenopausal Women
by: Subarna Mitra, et al.
Published: (2016-03-01) -
Relationship between Serum Lipid Profile and Hypertension
by: Faiq I. Gorial, et al.
Published: (2012-07-01)